However, these data demonstrate that LMP1-positive lymphomas have even higher sumo/SUMO levels than LMP1-negative lymphomas, which we propose is due to the activation of NF-κB by LMP1 CTAR1 and CTAR2. This evidence concerns the gene NFKB1 and lymphoma.